diabetes insipidus in mice lacking aquaporin-3 water channels.
Interpretation of IRT tests is complex, due to confounding factors such as age-related declines in IRT blood levels, prematurity, perinatal stress, fecal contamination of blood spots, trisomy 13 and 18, other serious congenital abnormalities, renal failure, bowel atresia, nephrogenic
diabetes insipidus, congenital infections, and neonatal blood transfusions (17-19).
We took into consideration for differential diagnosis several scleroderma-like disorders: eosinophilic fasciitis, localized and systemic sclerosis, nephrogenic
systemic fibrosis, scleromyxedema, scleredema and eosinophilia myalgia syndrome.
It consisted of both a proximal tubular injury with the combination of Fanconi syndrome and acute renal failure and a distal tubular injury in the form of nephrogenic
an impaired elimination of the drug), gadolinium-based contrast agents (GBCAs) may increase the risk for nephrogenic
systemic fibrosis (NSF), a rare and serious syndrome involving fibrosis of skin, joints, eyes and internal organs.
diabetes insipidus, hyperparathyroidism and hypothyroidism after lithium treatment.
adenoma (NA) is a rare benign proliferation in the urinary tract, usually occurring as a result of chronic inflammation, trauma or other similar chronic injuries to the urothelial mucosa.
Several other diseases can mimic calciphylaxis clinically: vasculitis, superfcial thrombophlebitis, purpura fulminans, warfarin necrosis, Martorell ischemic hypertensive ulcer, pyoderma gangrenosum, cholesterol embolization, oxalate vasculopathy, antiphospholipid syndrome, and nephrogenic
systemic fbrosis (8, 13).
About 90 percent of all cases of hereditary nephrogenic
diabetes insipidus result from mutations in the AVPR2 gene.
In 2006, the association between GBCA and nephrogenic
systemic fibrosis (NSF) was identified (1-3).
(39,40,42) Focal tubular differentiation may be present and can appear similar to nephrogenic
Package i: - mr contrast media (for intravenous injections) contrast medium for mr (intravenous) injections paramagnetic gadolinium - non-ionic, low risk of nephrogenic
systemic fibrosis (nsf) - by recommendations from the safety committee for contrast entities esur-version-10.